Stockreport

CryoPort Inc (CYRX) Q4 2025 Earnings Call Highlights: Record Growth in Cell and Gene Therapy Revenue [Yahoo! Finance]

CryoPort, Inc.  (CYRX) 
NASDAQ:AMEX Investor Relations: ir.cryoport.com
PDF Full-Year Revenue from Continuing Operations: $176.2 million, exceeding prior guidance. Fourth Quarter Commercial Cell and Gene Therapy Revenue: Increased 29% year ov [Read more]